Sarcoglycan, the heart, and skeletal muscles: new treatment, old drug?
- 15 January 2001
- journal article
- editorial
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 107 (2) , 153-154
- https://doi.org/10.1172/jci11998
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complexJournal of Clinical Investigation, 2001
- Mutations in the human δ-sarcoglycan gene in familial and sporadic dilated cardiomyopathyJournal of Clinical Investigation, 2000
- Lamin A/C Gene Mutation Associated With Dilated Cardiomyopathy With Variable Skeletal Muscle InvolvementCirculation, 2000
- Missense Mutations in the Rod Domain of the Lamin A/C Gene as Causes of Dilated Cardiomyopathy and Conduction-System DiseaseNew England Journal of Medicine, 1999
- Sarcoglycan complex: a muscular supporter of dystroglycan-dystrophin interplay?1999
- Desmin Mutation Responsible for Idiopathic Dilated CardiomyopathyCirculation, 1999
- Disruption of the Sarcoglycan–Sarcospan Complex in Vascular Smooth MuscleCell, 1999
- Heart involvement in muscular dystrophies due to sarcoglycan gene mutationsMuscle & Nerve, 1999
- Mapping a cardiomyopathy locus to chromosome 3p22-p25.Journal of Clinical Investigation, 1996
- X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus.Circulation, 1993